For citations:
Ershov N.M., Pshonkin A.V., Mareeva Yu.M., Yasko L.A., Kurnikova M.V., Evstratov D.A., Gobadze D.A., Papusha L.A., Ovsyannikova G.S., Rumyantsev A.G. The first experience of using MEK inhibitors for type 1 neurofibromatosis in children in the Russian Federation in a hospital for short-term treatment at the National Medical Research Center. Russian Journal of Pediatric Hematology and Oncology. 2021;8(1):85-92. (In Russ.) https://doi.org/10.21682/2311-1267-2021-8-1-85-92